The research scientist at Moffitt Cancer Center discussed the results of the preclinical study she presented at the 2023 AACR annual meeting and avenues for further research.
Leticia Tordesillas, PhD
Advertisement
Articles by Leticia Tordesillas, PhD
The research scientist at Moffitt Cancer Center shared the rationale behind the preclinical study she presented at the 2023 AACR annual meeting.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Guess the Therapy Answer October 29, 2025
4
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
5
